<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Liang H</submitter><funding>Breast Cancer Research Foundation (BCRF)</funding><funding>Breast Cancer Research Foundation</funding><funding>U.S. Department of Health &amp;amp; Human Services | NIH | National Cancer Institute</funding><funding>NCI NIH HHS</funding><pagination>986-1002</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12480652</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>133(7)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>The hybrid EMT state is a key driver of tumour regenerative and metastatic potential; however, the mechanism whereby this programme regulates tumour stemness with respect to self-renewal and differentiation remains unclear.&lt;h4>Methods&lt;/h4>We isolated epithelial/mesenchymal (E/M) (CD104&lt;sup>high&lt;/sup>CD44&lt;sup>high&lt;/sup>) and mesenchymal (M) (CD104&lt;sup>low&lt;/sup> CD44&lt;sup>high&lt;/sup>) subpopulations from basal-like breast cancer cell lines. These were assayed for tumour-initiating potential and organoid-forming ability, as well as for transcriptional regulators of the hybrid EMT state by RNA and ATAC-sequencing, and their regulation by the Wnt/ERK/CDK4/6 signalling pathway.&lt;h4>Results&lt;/h4>E/M cells were endowed with organoid-forming ability as well as by tumour-initiating an</pubmed_abstract><journal>British journal of cancer</journal><pubmed_title>Wnt/ERK/CDK4/6 activation in the partial EMT state coordinates mammary cancer stemness with self-renewal and inhibition of differentiation.</pubmed_title><pmcid>PMC12480652</pmcid><funding_grant_id>P01 CA257885</funding_grant_id><funding_grant_id>BCRF-18-066</funding_grant_id><pubmed_authors>Norton L</pubmed_authors><pubmed_authors>Kumar V</pubmed_authors><pubmed_authors>Griffen A</pubmed_authors><pubmed_authors>Zhang J</pubmed_authors><pubmed_authors>Ren Z</pubmed_authors><pubmed_authors>Sivalingam K</pubmed_authors><pubmed_authors>LaFave LM</pubmed_authors><pubmed_authors>Hazan RB</pubmed_authors><pubmed_authors>Wang J</pubmed_authors><pubmed_authors>Benard O</pubmed_authors><pubmed_authors>Liang H</pubmed_authors><pubmed_authors>Zhang X</pubmed_authors><pubmed_authors>Suyama K</pubmed_authors><pubmed_authors>de Simone Benito E</pubmed_authors></additional><is_claimable>false</is_claimable><name>Wnt/ERK/CDK4/6 activation in the partial EMT state coordinates mammary cancer stemness with self-renewal and inhibition of differentiation.</name><description>&lt;h4>Background&lt;/h4>The hybrid EMT state is a key driver of tumour regenerative and metastatic potential; however, the mechanism whereby this programme regulates tumour stemness with respect to self-renewal and differentiation remains unclear.&lt;h4>Methods&lt;/h4>We isolated epithelial/mesenchymal (E/M) (CD104&lt;sup>high&lt;/sup>CD44&lt;sup>high&lt;/sup>) and mesenchymal (M) (CD104&lt;sup>low&lt;/sup> CD44&lt;sup>high&lt;/sup>) subpopulations from basal-like breast cancer cell lines. These were assayed for tumour-initiating potential and organoid-forming ability, as well as for transcriptional regulators of the hybrid EMT state by RNA and ATAC-sequencing, and their regulation by the Wnt/ERK/CDK4/6 signalling pathway.&lt;h4>Results&lt;/h4>E/M cells were endowed with organoid-forming ability as well as by tumour-initiating an</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Oct</publication><modification>2026-06-03T23:33:23.498Z</modification><creation>2026-05-03T03:11:27.453Z</creation></dates><accession>S-EPMC12480652</accession><cross_references><pubmed>40764669</pubmed><doi>10.1038/s41416-025-03074-6</doi></cross_references></HashMap>